{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:22:34Z","timestamp":1789694554895,"version":"4.0.1"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0108389","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T18:03:19Z","timestamp":1411149799000},"page":"e108389","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Pituitary Adenylate Cyclase-Activating Polypeptide Ameliorates Experimental Acute Ileitis and Extra-Intestinal Sequelae"],"prefix":"10.1371","volume":"9","author":[{"given":"Markus M.","family":"Heimesaat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildiko R.","family":"Dunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Grundmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Alutis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja A.","family":"K\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miklos P.","family":"Dunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf B.","family":"G\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Reglodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bereswill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0006-291X(89)91757-9","article-title":"Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells","volume":"164","author":"A Miyata","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0031-6997(24)01449-2","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions","volume":"52","author":"D Vaudry","year":"2000","journal-title":"Pharmacol Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1196\/annals.1317.031","article-title":"VIP-PACAP system in immunity: new insights for multitarget therapy","volume":"1070","author":"RP Gomariz","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/156802606775270288","article-title":"Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP","volume":"6","author":"C Abad","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/pr.109.001370","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery","volume":"61","author":"D Vaudry","year":"2009","journal-title":"Pharmacol Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.4049\/jimmunol.167.6.3182","article-title":"Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: an experimental immunomodulatory therapy","volume":"167","author":"C Abad","year":"2001","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1191\/1352458504ms1096oa","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells","volume":"10","author":"H Kato","year":"2004","journal-title":"Mult Scler"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/ijc.23308","article-title":"Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP","volume":"122","author":"N Nemetz","year":"2008","journal-title":"Int J Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jcp.21381","article-title":"PACAP provides colonic protection against dextran sodium sulfate induced colitis","volume":"216","author":"YT Azuma","year":"2008","journal-title":"J Cell Physiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/gast.2003.50141","article-title":"Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn&apos;s disease","volume":"124","author":"C Abad","year":"2003","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/bega.2002.0354","article-title":"The current future understanding of inflammatory bowel disease","volume":"16","author":"DK Podolsky","year":"2002","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"DK Podolsky","year":"2002","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3184\/003685002783238861","article-title":"Inflammatory bowel disease: is the intestine a Trojan horse?","volume":"85","author":"C Basset","year":"2002","journal-title":"Sci Prog"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.184.2.597","article-title":"Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with <italic>Toxoplasma gondii<\/italic>","volume":"184","author":"O Liesenfeld","year":"1996","journal-title":"J Exp Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"13955","DOI":"10.1073\/pnas.94.25.13955","article-title":"A dichotomous role for nitric oxide during acute <italic>Toxoplasma gondii<\/italic> infection in mice","volume":"94","author":"IA Khan","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.4049\/jimmunol.168.6.2988","article-title":"Lamina propria CD4+ T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen","volume":"168","author":"FJ Mennechet","year":"2002","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1002\/eji.200424993","article-title":"Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with <italic>Toxoplasma gondii<\/italic>, but IL-12 is dominant over IL-18 in parasite control","volume":"34","author":"A Vossenkamper","year":"2004","journal-title":"Eur J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1462-5822.2006.00692.x","article-title":"Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections","volume":"8","author":"D Buzoni-Gatel","year":"2006","journal-title":"Cell Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1084\/jem.20090900","article-title":"Interleukin (IL)-23 mediates <italic>Toxoplasma gondii<\/italic>-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17","volume":"206","author":"M Munoz","year":"2009","journal-title":"J Exp Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/mi.2010.8","article-title":"IL-10 production by CD4+ effector T cells: a mechanism for self-regulation","volume":"3","author":"D Jankovic","year":"2010","journal-title":"Mucosal Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.4049\/jimmunol.177.12.8785","article-title":"Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with <italic>Toxoplasma gondii<\/italic>","volume":"177","author":"MM Heimesaat","year":"2006","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/gut.2006.104497","article-title":"Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal <italic>Escherichia coli<\/italic>","volume":"56","author":"MM Heimesaat","year":"2007","journal-title":"Gut"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e9125","DOI":"10.1371\/journal.pone.0009125","article-title":"The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5","volume":"5","author":"C Erridge","year":"2010","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1086\/338006","article-title":"Oral infection of C57BL\/6 mice with <italic>Toxoplasma gondii<\/italic>: a new model of inflammatory bowel disease?","volume":"185","author":"O Liesenfeld","year":"2002","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-065X.2010.00992.x","article-title":"Immunology of <italic>Toxoplasma gondii<\/italic>","volume":"240","author":"M Munoz","year":"2012","journal-title":"Immunol Rev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1556\/EuJMI.3.2013.1.5","article-title":"Can microbiota transplantation abrogate murine colonization resistance against <italic>Campylobacter jejuni<\/italic>?","volume":"3","author":"MM Heimesaat","year":"2013","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e15099","DOI":"10.1371\/journal.pone.0015099","article-title":"Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation","volume":"5","author":"S Bereswill","year":"2010","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1371\/journal.pone.0000662","article-title":"Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4","volume":"2","author":"MM Heimesaat","year":"2007","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e20953","DOI":"10.1371\/journal.pone.0020953","article-title":"Novel Murine Infection Models Provide Deep Insights into the \u201cMenage a Trois\u201d of <italic>Campylobacter jejuni<\/italic>, Microbiota and Host Innate Immunity","volume":"6","author":"S Bereswill","year":"2011","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e40761","DOI":"10.1371\/journal.pone.0040761","article-title":"<italic>Campylobacter jejuni<\/italic> induces acute enterocolitis in gnotobiotic IL-10\u2212\/\u2212 mice via Toll-like-receptor-2 and -4 signaling","volume":"7","author":"LM Haag","year":"2012","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MED.0b013e328342568a","article-title":"VIP and PACAP: recent insights into their functions\/roles in physiology and disease from molecular and genetic studies","volume":"18","author":"TW Moody","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/cdd.2008.161","article-title":"Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death","volume":"16","author":"M Delgado","year":"2009","journal-title":"Cell Death Differ"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1196\/annals.1317.032","article-title":"VIP: an agent with license to kill infective parasites","volume":"1070","author":"E Gonzalez-Rey","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0165-5728(95)00105-6","article-title":"Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP","volume":"62","author":"M Delgado","year":"1995","journal-title":"J Neuroimmunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/154411130201300303","article-title":"Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity","volume":"13","author":"D Ganea","year":"2002","journal-title":"Crit Rev Oral Biol Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1146\/annurev.pa.35.040195.003255","article-title":"Macrophages and inflammatory mediators in tissue injury","volume":"35","author":"DL Laskin","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4049\/jimmunol.167.2.966","article-title":"Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo","volume":"167","author":"M Delgado","year":"2001","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1073\/pnas.0812257106","article-title":"Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis","volume":"106","author":"YV Tan","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e61200","DOI":"10.1371\/journal.pone.0061200","article-title":"Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE","volume":"8","author":"YV Tan","year":"2013","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1196\/annals.1317.020","article-title":"Vasoactive intestinal peptide: the dendritic cell\u2192regulatory T cell axis","volume":"1070","author":"M Delgado","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.4049\/jimmunol.175.11.7311","article-title":"The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells","volume":"175","author":"M Delgado","year":"2005","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.humimm.2009.01.020","article-title":"Generating tolerogenic dendritic cells with neuropeptides","volume":"70","author":"M Delgado","year":"2009","journal-title":"Hum Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.4049\/jimmunol.163.7.3629","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression","volume":"163","author":"M Delgado","year":"1999","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1757-4749-6-19","article-title":"The impact of Toll-like-receptor-9 on intestinal microbiota composition and extra-intestinal sequelae in experimental <italic>Toxoplasma gondii<\/italic> induced ileitis","volume":"6","author":"S Bereswill","year":"2014","journal-title":"Gut Pathog"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1556\/EuJMI.1.2011.3.7","article-title":"Selective gelatinase blockage ameliorates acute DSS colitis","volume":"1","author":"MM Heimesaat","year":"2011","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4049\/jimmunol.162.3.1707","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies","volume":"162","author":"M Delgado","year":"1999","journal-title":"J Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.2003.tb03145.x","article-title":"PACAP in immunity and inflammation","volume":"992","author":"M Delgado","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1317.093","article-title":"Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38","volume":"1070","author":"A Arimura","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2310\/JIM.0b013e31821452a2","article-title":"Renoprotection with pituitary adenylate cyclase-activating polypeptide in cyclosporine A-induced nephrotoxicity","volume":"59","author":"AM Khan","year":"2011","journal-title":"J Investig Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.npep.2010.12.003","article-title":"Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) show increased susceptibility to in vivo renal ischemia\/reperfusion injury","volume":"45","author":"P Szakaly","year":"2011","journal-title":"Neuropeptides"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12031-010-9428-8","article-title":"Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells","volume":"43","author":"G Horvath","year":"2011","journal-title":"J Mol Neurosci"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/hep.25802","article-title":"Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway","volume":"57","author":"H Ji","year":"2013","journal-title":"Hepatology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.peptides.2011.05.008","article-title":"Pituitary adenylate cyclase-activating polypeptide plays an anti-inflammatory role in endotoxin-induced airway inflammation: in vivo study with gene-deleted mice","volume":"32","author":"K Elekes","year":"2011","journal-title":"Peptides"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.regpep.2004.04.023","article-title":"Long-lasting smooth-muscle relaxation by a novel PACAP analogue in human bronchi","volume":"123","author":"S Yoshihara","year":"2004","journal-title":"Regul Pept"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1089\/neu.2011.2244","article-title":"Exogenous administration of PACAP alleviates traumatic brain injury in rats through a mechanism involving the TLR4\/MyD88\/NF-kappaB pathway","volume":"29","author":"SS Mao","year":"2012","journal-title":"J Neurotrauma"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1002\/1521-4141(200011)30:11<3236::AID-IMMU3236>3.0.CO;2-L","article-title":"Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock","volume":"30","author":"M Delgado","year":"2000","journal-title":"Eur J Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.162.2.1200","article-title":"Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6","volume":"162","author":"M Delgado","year":"1999","journal-title":"J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0108389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T18:46:43Z","timestamp":1746384403000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0108389"}},"subtitle":[],"editor":[{"given":"Leo T. O.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,19]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0108389","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,19]]}}}